RS5-Catechin from Tropical Almond Seeds: New Hope for Alzheimer's
Alzheimer’s disease is a neurodegenerative disorder whose prevalence is steadily increasing globally. Over the last three decades, the number of deaths due to Alzheimer’s has risen from 651,000 to 1.4 million. The burden of this disease is projected to continue rising, with global cases estimated to reach 152 million by 2050. In Indonesia, the number of individuals affected by Alzheimer’s is estimated to have reached 4.2 million. To date, various therapeutic strategies have been developed, but no therapy exists that can definitively halt the progression of the disease.
Alzheimer’s: A Growing Health Threat
In an effort to address this challenge, a team of students from Andalas University has developed an innovative approach by utilising waste from tropical almond seeds (Terminalia catappa) as a source of Type 5 Resistant Starch (RS5). This approach is combined with catechin, a natural antioxidant compound with the potential to inhibit the process of β-amyloid aggregation. β-amyloid aggregation is one of the primary pathological characteristics associated with the development of Alzheimer’s disease.
One of the obstacles in using catechin as a bioactive agent is its relatively low stability against acidic conditions in the stomach, which can lead to degradation before reaching the target site. In this approach, RS5 acts as a protective matrix for the catechin. The RS5-catechin complex is designed to be resistant to the digestive processes in the stomach and small intestine, allowing the catechin to remain protected within the digestive tract and potentially be released in the colon.
The Gut-Brain Axis Strategy
This approach utilises the gut-brain axis mechanism, which is a two-way communication pathway connecting gut microbiota with the function and health of the central nervous system. Within the colon, the RS5-catechin can undergo fermentation by gut microbiota to produce Short-Chain Fatty Acids (SCFA), particularly acetate, propionate, and butyrate. These metabolites have the potential to provide neuroprotective effects through the modulation of inflammatory responses and metabolic functions, thereby contributing to the reduction of neuroinflammation associated with the pathogenesis of Alzheimer’s disease, including processes related to β-amyloid accumulation in the brain.
From Local Waste to Global Contribution
The research, conducted by Febi Febianti alongside a team consisting of Habibi Yudhistira, Dzaky Kurniawan, Winia Novita Lestaria, and Atika Yudistira, focuses on the use of agricultural waste as a source of functional materials with potential therapeutic value. This innovation is expected to increase the utility of tropical almond seeds, which have hitherto not been optimally utilised, while simultaneously opening opportunities for their development as candidate functional ingredients in preventive and therapeutic approaches to Alzheimer’s disease. The results of this research are planned for publication in the International Journal of Natural Medicine, with information also shared via the Instagram account @CataCogni.pkmre.
Tropical almond seeds, which are often viewed as waste, actually possess the potential to be developed into a valuable source of health-promoting functional materials. Such utilisation is expected to serve as an initial step in developing more affordable and sustainable approaches to Alzheimer’s disease, based on Indonesia’s diverse biological potential.
Source: jawawa.id (https://jawawa.id/newsitem/rs5-catechin-from-tropical-almond-seeds-new-hope-for-alzheimers-1789523853)
Originally published by Republika (https://retizen.republika.co.id/posts/781746/rs5-katekin-dari-biji-ketapang-harapan-baru-untuk-alzheimer), translated from Indonesian